Yang Arvin
- SEC CIK
- 0001834321
No open-market purchases or sales filed in the past year.
Current role at each company
- MRSN Mersana Therapeutics, Inc.SVP, Chief Medical Officeras of Jan 18, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yang Arvin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Yang ArvinSVP, Chief Medical Officer | SSale | −2.21K | $5.74 | −$12.7K | −6.7%30.8K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Yang ArvinChief Medical Officer | SSale | −5.53K | $6.59 | −$36.4K | −17.6%25.9K after | |
| Dec 2, 2021 (view filing) | Dec 1 | 1 day | Yang ArvinChief Medical Officer | SSale | −5.53K | $6.81 | −$37.6K | −29.9%13.0K after |